Akari Therapeutics has reaffirmed its commitment to advancing research on PH1, a novel spliceosome modulator payload used in ...

Akari Therapeutics plc announced that it is continuing key research on its antibody-drug conjugate (ADC) payload PH1 to ...

Video webcasts from participating companies now available here FRENCHTOWN, NJ / ACCESS Newswire / July 22, 2025 / JTC Team ...

Video webcast now available on-demandBOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...

Fintel reports that on July 18, 2025, Maxim Group initiated coverage of Akari Therapeutics, Plc - Depositary Receipt () ...

Video webcasts to be available on-demand Tuesday, July 22nd FRENCHTOWN, NJ / ACCESS Newswire / July 18, 2025 / JTC Team (“JTC ...

Maxim analyst Jason McCarthy initiated coverage of Akari Therapeutics (AKTX) with a Buy rating and $5 price target Published first on TheFly – the ...

MARS Alba made a stunning preseason move to trade purple for pink and join Akari. It ended nearly a year-long stint with ...

Multiple insiders secured a larger position in Akari Therapeutics, Plc ( NASDAQ:AKTX ) shares over the last 12 ...

AKARI restored its winning form against Capital1, 25-23, 25-18, 26-24, in the 2025 PVL on Tour on Tuesday at the Playtime ...

Akari crawled back from eight points down in the third set en route to a 25-23, 25-18, 25-23 win against Capital1 in the 2025 ...

The Paroxysmal Nocturnal Hemoglobinuria treatment market is experiencing significant expansion, driven by increasing disease awareness, rising preval ...